scispace - formally typeset
D

Daniel P. Bezerra

Researcher at Oswaldo Cruz Foundation

Publications -  148
Citations -  3840

Daniel P. Bezerra is an academic researcher from Oswaldo Cruz Foundation. The author has contributed to research in topics: Apoptosis & In vivo. The author has an hindex of 31, co-authored 132 publications receiving 3024 citations. Previous affiliations of Daniel P. Bezerra include Universidade Federal de Sergipe & Federal University of Ceará.

Papers
More filters
Journal ArticleDOI

Overview of the therapeutic potential of piplartine (piperlongumine).

TL;DR: It is concluded that piplartine is effective for use in cancer therapy and its safety using chronic toxicological studies should be addressed to support the viability of clinical trials.
Journal ArticleDOI

In vivo growth-inhibition of Sarcoma 180 by piplartine and piperine, two alkaloid amides from Piper.

TL;DR: Histopathological and morphological analyses of the tumor and the organs, including liver, spleen, and kidney, were performed in order to evaluate the toxicological aspects of the treatment with these amides and it was shown that both organs were reversibly affected by piplartine and piperine treatment, but in a different way.
Journal ArticleDOI

Antitumor properties of a sulfated polysaccharide from the red seaweed Champia feldmannii (Diaz‐Pifferer)

TL;DR: Cf‐PLS has some interesting anticancer activity that could be associated with its immunostimulating properties, and acts as an immunomodulatory agent, raising theproduction of specific antibodies, and increasing the production of OVA‐specific antibodies.
Journal ArticleDOI

In vitro and in vivo antitumor effect of 5-FU combined with piplartine and piperine

TL;DR: Piplartine may enhance the therapeutic effectiveness of chemotherapeutic drugs, and moreover, this combination could improve immunocompetence hampered by 5‐FU, according to the findings.